• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

委内瑞拉乳腺癌患者的 BRCA1 和 BRCA2 突变。

BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.

机构信息

Laboratorio de Genética Molecular Humana B, Departamento de Biología Celular, Universidad Simón Bolívar, Caracas, Venezuela.

出版信息

Biol Res. 2012;45(2):117-30. doi: 10.4067/S0716-97602012000200003.

DOI:10.4067/S0716-97602012000200003
PMID:23096355
Abstract

A sample of 58 familial breast cancer patients from Venezuela were screened for germline mutations in the coding sequences and exon-intron boundaries of BRCA1 (MIM no. 113705) and BRCA2 (MIM no. 600185) genes by using conformation-sensitive gel electrophoresis. Ashkenazi Jewish founder mutations were not found in any of the samples. We identified 6 (10.3%) and 4 (6.9%) patients carrying germline mutations in BRCA1 and BRCA2, respectively. Four pathogenic mutations were found in BRCA1, one is a novel mutation (c.951_952insA), while the other three had been previously reported (c.1129_1135insA, c.4603G>T and IVS20+1G>A). We also found 4 pathogenic mutations in BRCA2, two novel mutations (c.2732_2733insA and c.3870_3873delG) and two that have been already reported (c.3036_3039delACAA and c.6024_6025_delTA). In addition, 17 variants of unknown significance (6 BRCA1 variants and 11 BRCA2 variants), 5 BRCA2 variants with no clinical importance and 22 polymorphisms (12 in BRCA1 and 10 in BRCA2) were also identified. This is the first genetic study on BRCA gene mutations conducted in breast cancer patients from Venezuela. The ethnicity of our population, as well as the heterogeneous and broad spectrum of BRCA genes mutations, must be considered to optimize genetic counseling and disease prevention in affected families.

摘要

从委内瑞拉的 58 个家族性乳腺癌患者中抽取样本,通过构象敏感凝胶电泳法对 BRCA1(MIM 编号:113705)和 BRCA2(MIM 编号:600185)基因的编码序列和外显子-内含子边界进行种系突变筛查。在任何样本中均未发现阿什肯纳兹犹太裔的突变。我们分别在 BRCA1 和 BRCA2 中发现了 6(10.3%)和 4(6.9%)名患者存在种系突变。在 BRCA1 中发现了 4 种致病性突变,其中 1 种是新突变(c.951_952insA),另外 3 种之前已有报道(c.1129_1135insA、c.4603G>T 和 IVS20+1G>A)。在 BRCA2 中,我们还发现了 4 种致病性突变,其中 2 种是新突变(c.2732_2733insA 和 c.3870_3873delG),另外 2 种已有报道(c.3036_3039delACAA 和 c.6024_6025_delTA)。此外,还鉴定出了 17 种意义不明的变异(6 种 BRCA1 变异和 11 种 BRCA2 变异)、5 种无临床意义的 BRCA2 变异和 22 种多态性(BRCA1 中有 12 种,BRCA2 中有 10 种)。这是委内瑞拉乳腺癌患者中进行的首次 BRCA 基因突变的遗传研究。我们的人群种族以及 BRCA 基因突变的异质性和广泛谱型,必须加以考虑,以优化受影响家族的遗传咨询和疾病预防。

相似文献

1
BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.委内瑞拉乳腺癌患者的 BRCA1 和 BRCA2 突变。
Biol Res. 2012;45(2):117-30. doi: 10.4067/S0716-97602012000200003.
2
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.印度乳腺癌患者中乳腺癌易感基因BRCA1、BRCA2和p53基因的新型种系突变。
Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8.
3
BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.韩国散发性乳腺癌患者的BRCA1和BRCA2种系突变
Hum Mutat. 2004 Oct;24(4):350. doi: 10.1002/humu.9275.
4
BRCA1 and BRCA2 mutations in a South American population.南美人群中的BRCA1和BRCA2基因突变
Cancer Genet Cytogenet. 2006 Apr 1;166(1):36-45. doi: 10.1016/j.cancergencyto.2005.08.019.
5
BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.乌拉圭乳腺癌和乳腺癌-卵巢癌家族的 BRCA1 和 BRCA2 种系突变。新突变和未分类变异体的鉴定。
Breast Cancer Res Treat. 2011 Jul;128(1):211-8. doi: 10.1007/s10549-010-1320-2. Epub 2010 Dec 29.
6
Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.土耳其乳腺癌/卵巢癌患者BRCA1和BRCA2基因的种系突变
Hum Mutat. 2003 Apr;21(4):444-5. doi: 10.1002/humu.9119.
7
Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.斯洛伐克遗传性乳腺癌和/或卵巢癌家族中的阿什肯纳兹始祖BRCA1/BRCA2突变
Neoplasma. 2006;53(2):97-102.
8
[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].[加拿大魁北克奠基人群体法裔加拿大乳腺癌和乳腺-卵巢癌家族中致病性BRCA1和BRCA2突变的有限谱]
Bull Cancer. 2006 Sep;93(9):841-6.
9
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.对患有家族性乳腺癌和卵巢癌的德系犹太及非德系犹太女性的BRCA1和BRCA2进行突变分析。
Hum Mutat. 2000 Dec;16(6):491-501. doi: 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.0.CO;2-J.
10
Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.区分BRCA1和BRCA2剪接位点的致病性突变与多态性改变。
Genes Chromosomes Cancer. 2003 Jul;37(3):314-20. doi: 10.1002/gcc.10221.

引用本文的文献

1
BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific.来自哥伦比亚太平洋地区的乳腺癌和卵巢癌家族样本中的BRCA1和BRCA2突变
Colomb Med (Cali). 2019 Sep 30;50(3):163-175. doi: 10.25100/cm.v50i3.2385.
2
The Expression Level of and Its Changes during Chemotherapy in Patients with Different Pathological Types of Mammary Cancer.不同病理类型乳腺癌患者化疗期间的表达水平及其变化
Iran J Public Health. 2019 Sep;48(9):1654-1662.
3
Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.
拉美乳腺癌中 DNA 修复基因种系突变的全景:PARP 抑制剂和免疫疗法的机会。
Genes (Basel). 2019 Oct 10;10(10):786. doi: 10.3390/genes10100786.
4
Mutational analysis of BRCA1 and BRCA2 genes in women with familial breast cancer from different regions of Colombia.对来自哥伦比亚不同地区的家族性乳腺癌女性患者的BRCA1和BRCA2基因进行突变分析。
Hered Cancer Clin Pract. 2019 Jul 15;17:20. doi: 10.1186/s13053-019-0120-x. eCollection 2019.
5
Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America.局部晚期乳腺癌的精准医学:拉丁美洲的前沿与挑战
Ecancermedicalscience. 2019 Jan 22;13:896. doi: 10.3332/ecancer.2019.896. eCollection 2019.
6
and founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.在智利的遗传性乳腺癌家族中,奠基者突变占胚系携带者的78%。
Oncotarget. 2017 Jun 29;8(43):74233-74243. doi: 10.18632/oncotarget.18815. eCollection 2017 Sep 26.
7
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.中美洲和南美洲人群中BRCA1、BRCA2及其他乳腺癌和卵巢癌易感基因的突变
Biol Res. 2017 Oct 6;50(1):35. doi: 10.1186/s40659-017-0139-2.
8
State of Art of Cancer Pharmacogenomics in Latin American Populations.拉丁美洲人群癌症药物基因组学的现状
Int J Mol Sci. 2017 May 23;18(6):639. doi: 10.3390/ijms18060639.
9
Genetic Cancer Risk Assessment for Breast Cancer in Latin America.拉丁美洲乳腺癌的遗传癌症风险评估
Rev Invest Clin. 2017 Mar-Apr;69(2):94-102. doi: 10.24875/ric.17002195.
10
Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.拉丁裔人群中的遗传性癌症综合征:基因特征与监测指南
Hered Cancer Clin Pract. 2017 Jan 21;15:3. doi: 10.1186/s13053-017-0063-z. eCollection 2017.